Russian Federation became the first country to officially register the COVID-19 vaccine.
Chairing a meeting to review the COVID-19 pandemic situation and the preparedness of vaccine delivery, distribution, and administration, the prime minister also noted a steady decline in the daily cases and the growth rate.
A US$60 (B1872) double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Worldwide, there are 40 candidates in the race of vaccination.
But since it was tested on a small number of people in Russia, DCGI had initially expressed doubts over the Sputnik V vaccine candidate being tested among a bigger population in India. "The Sputnik V vaccine, which is based on well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the coronavirus pandemic", a statement from the Russian fund had earlier stated.
The detailed 148-page plan notes that the groups of people getting a vaccine first will be reevaluated over time. The WHO has also taken initiative to make the process fast and easy, " Dr Suresh Jadav, Executive Director, Serum Institute of India, Pvt Ltd., Pune, said while addressing India Vaccine Accessibility e-Summit at HEAL-Thy Samvaad and throwing light on - where do we stand in COVID-19 vaccine development.
Is there hope for the world to see a vaccine at the end of 2020? "Thereafter, we will produce more and more dosages by the permission of the government", added Dr Jadav.
Officials in Jiaxing city said on Thursday that residents aged between 18 and 59 with "urgent needs" can approach clinics for treatment with a Sinovac Biotech vaccine that authorities have been giving to groups such as medical workers. In comments to the media, scientists developing the vaccine said that it produced enough antibodies to protect the person who had it from the virus and that the immunity it creates could last for up to six months.
We now need to increase production of the first vaccine and the second vaccine, Putin said.
Elaborating on the status of the vaccine development during HEAL-Thy Samvaad, Mr Samir Deb, pharmaceutical professional, consultant vaccine & public affairs consultant, South East Asia, said, "Vaccine development is a burning issue across the world now".
The shots, which include the booster dose, are planned for the initial phase once a vaccine is approved for use.